Daiwa Securities Group Inc. Rocket Pharmaceuticals, Inc. Transaction History
Daiwa Securities Group Inc.
- $27.1 Billion
- Q2 2025
A detailed history of Daiwa Securities Group Inc. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 304 shares of RCKT stock, worth $1,298. This represents 0.0% of its overall portfolio holdings.
Number of Shares
304
Previous 304
-0.0%
Holding current value
$1,298
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding RCKT
# of Institutions
222Shares Held
98.5MCall Options Held
611KPut Options Held
474K-
Rtw Investments, LP New York, NY17.7MShares$75.5 Million0.67% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.36MShares$35.7 Million0.35% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$26.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.12MShares$26.1 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.82MShares$20.6 Million0.17% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $323M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...